0001209191-23-050674.txt : 20230927
0001209191-23-050674.hdr.sgml : 20230927
20230927171348
ACCESSION NUMBER: 0001209191-23-050674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230926
FILED AS OF DATE: 20230927
DATE AS OF CHANGE: 20230927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Himawan Jeff
CENTRAL INDEX KEY: 0001342821
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 231285449
MAIL ADDRESS:
STREET 1: ESSEX WOODLANDS HEALTH VENTURES
STREET 2: 435 TASSO STREET, SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-26
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001342821
Himawan Jeff
C/O HORIZON THERAPEUTICS PLC,
70 ST. STEPHEN?S GREEN
DUBLIN
L2
D02 E2X4
IRELAND
1
0
0
0
0
Ordinary Shares
2023-09-26
4
M
0
32161
13.87
A
44546
D
Ordinary Shares
7873
I
By Pt Rd Foundation
Ordinary Shares
36609
I
By Trust
Stock Option (Right to Buy)
13.87
2023-09-26
4
M
0
32161
0.00
D
2028-05-02
Ordinary Shares
32161
0
D
10,264 shares previously reported as held indirectly by Trust are now held directly.
The stock option is fully vested.
/s/ Meghanne Downes, Attorney-in-Fact
2023-09-27